Global Mastopexy Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

The Mastopexy Market is segmented by Technique (Crescent Breast Lift, Benelli Lift, Benelli-Lollipop Lift, and Full Mastopexy), By End-Use (Hospitals, Ambulatory Surgery Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Market Snapshot
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 5.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Mastopexy market studied is expected to grow with an estimated CAGR of 5.7% over the forecast period

As the COVID-19 pandemic progressed with new strains, the safety of ablative resurfacing lasers, micro-needling, and dermatological surgery procedures also seemed to be unsafe. Additionally, the slowing economy and reduced discretionary spending discourage customers from undergoing expensive cosmetic treatments, thus imposing practical restrictions. As per the Plastic Surgery Statistics Report from year 2020 states that total population of 87,051 patients underwent the mastopexy surgery in 2020.

Rising female geriatric population and growing demands for aesthetic procedures are estimated to drive the market growth during the forecast period.Increased healthcare expenditures along with the growing demands for outpatient surgeries is boosting the market growth. However, factors such as high cost for mastopexy followed by complications of the surgery are estimated to restrain the market growth during the forecast period.

Scope of the Report

As per the scope of the report, mastopexy, also known as breast lift, is a cosmetic breast surgery procedure that lifts the breasts and shape sagging or ptotic breast while minimizing visible scars. The procedure also eliminates excess skin around the breasts and shrinks the areola. The Mastopexy Market is segmented by Technique (Crescent Breast Lift, Benelli Lift, Benelli-Lollipop Lift, and Full Mastopexy), By End-Use (Hospitals, Ambulatory Surgery Centers, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Technique
Benelli Lift
Crescent Breast Lift
Benelli-Lollipop Lift
Full Mastopexy
By End use
Speciality Clinics
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of the Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Full mastopexy segment is Expected to dominate the market over the forecast period

Based on technique, the full mastopexy segment held a majority of the market share in terms of revenue. The full mastopexy procedure is performed in cases of breast sagginess, which is mainly observed in older women. Mastopexy also performed in breast cancer patients who undergo mastectomy and lumpectomy. During the procedure, the surgeons tend to remove cancerous tissues, which can led to breast reconstruction surgery. According to the American Cancer Society, it was estimated that 287,850 new cases of invasive breast cancer will be diagnosed in the United States in 2022. The high incidence of breast cancer can thus boost the market growth.

The mastopexy restores the volume and fullness of the breasts with or without the use of implants. As per the Aesthetic Society article published in April 2022, the annual statistics breast surgical procedures in 2021, accounted for 48% growth as compared to 2020. There were 365,000 breast augmentations performed in 2021 . Thus, the increase in the number of breast augmention will help to propel the demand for full mastopexy during the forecast period.

from year 2020 states that total population of 87,051 preformed the mastopexy surgery

North America is projected to have a Prominent Growth Rate

North America region is the majority share contributor to the market revenue in 2021 and is expected to continue in the next years. Some of the factors driving regional growth include the rising demand for aesthetic procedures among women and increased disposable income. According to the American Society of Plastic Surgeons figures,the new and imaginative ways to shape the bodies are been developed, with minimally invasive cosmetic operations increasing nearly 200 percent since 2000. Breast enhancement is one of the top cosmetic surgical procedures performed in the NorthAmerica region.In the United States, breast cancer is one of the leading cancer types. According to the, updated in January 2022, about 1 in 8 women (about 13%) will develop invasive breast cancer over the lifetime.

The demand for cosmetic surgeries and procedures in the United States is very high among women, which is one of the significant factors for the growth of the mastopexy market in the region. For instance, according to the 2020 report of the American Society of Plastic Surgeons, breast augmentation was one of the top five cosmetic surgical procedures performed in 2020 in the United States. Moreover, the total number was 193,073 breast augmentation procedures in 2020. In addition, the increasing prevalence of breast cancer in North America will also complement the growth of the breast implant market in the region. As per the GLOBOCAN 2020 report, the new breast cancer cases in the United States, Canada, and Mexico were 253,465, 28,026, and 29,929, respectively, in 2020. Therefore, North America is expected to hold a significant market share in the breast implant market during the forecast period.


Competitive Landscape

The mastopexy market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Allergan, Sientra, Inc,Ideal Implant Incorporated, Johnson & Johnson, Establishment Labs, POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebin SAS, Integra LifeSciences, and GC Aesthetics.

Recent Development

In May 2021, GC Aesthetics Inc. announced the launch of its next generation of breast implants, PERLE. PERLE is a highly innovative line of smooth breast implants that features proprietary surface technology, GCA's industry-leading gel technology, and an enhanced version of the safety features that have underpinned GCA's long-term excellent safety record.

In February 2021, Galderma announced the approval of RESTYLANE DEFYNE by the United States Food and Drug Administration for the augmentation and correction of mild to moderate chin retrusion for adults over 21 years

Table of Contents


    1. 1.1 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing adoption of breast lifting procedures

      2. 4.2.2 Growing prominence on physical appearance

      3. 4.2.3 Rising female geriatric population

      4. 4.2.4 Rising trend of aesthetic procedures

    3. 4.3 Market Restraints

      1. 4.3.1 High cost of these procedures

      2. 4.3.2 Post-surgery complications

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Technique

      1. 5.1.1 Benelli Lift

      2. 5.1.2 Crescent Breast Lift

      3. 5.1.3 Benelli-Lollipop Lift

      4. 5.1.4 Full Mastopexy

    2. 5.2 By End use

      1. 5.2.1 Speciality Clinics

      2. 5.2.2 Hospitals

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. United Kingdom

        2. Germany

        3. France

        4. Spain

        5. Italy

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. India

        2. Japan

        3. China

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of the Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Allergan

      2. 6.1.2 Mentor Word Wide LLC

      3. 6.1.3 GC Aesthetics

      4. 6.1.4 Lipoclastic

      5. 6.1.5 Cynosure

      6. 6.1.6 Polytech Health & Aesthetics

      7. 6.1.7 Sientra

      8. 6.1.8 Galderma

      9. 6.1.9 Lumenis

      10. 6.1.10 Solta Medical

      11. 6.1.11 Syneron Medical

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Mastopexy Market market is studied from 2019 - 2027.

The Global Mastopexy Market is growing at a CAGR of 5.7% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Allergan, Sientra, Integra, Polytech, Johnson & Johnson are the major companies operating in Global Mastopexy Market .

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!